Saif Advisors Ltd is an investment fund managing more than $438 million ran by Wan, Tao. There are currently 3 companies in Tao’s portfolio. The largest investments include Sinovac Biotech and Huize Hldg Ltd, together worth $435 million.
As of 4th August 2021, Saif Advisors Ltd’s top holding is 10,780,820 shares of Sinovac Biotech currently worth over $405 million and making up 92.6% of the portfolio value.
Relative to the number of outstanding shares of Sinovac Biotech, Saif Advisors Ltd owns more than 0.1% of the company.
In addition, the fund holds 4,955,243 shares of Huize Hldg Ltd worth $29.5 million.
The third-largest holding is Qk Intl Group Ltd worth $2.68 million.
Currently, Saif Advisors Ltd's portfolio is worth at least $438 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Saif Advisors Ltd office and employees reside in Admiralty, Hong Kong. According to the last 13-F report filed with the SEC, Wan, Tao serves as the DIRECTOR at Saif Advisors Ltd.
Wan, Tao disclosed a decreased stake in Huize Hldg Ltd by 0.3%.
This leaves the value of the investment at $29.5 million and 4,955,243 shares.
The two most similar investment funds to Saif Advisors Ltd are Jbf Capital and Patton Albertson Miller Group. They manage $438 million and $438 million respectively.
Saif Advisors Ltd’s portfolio is diversified across 2 sectors.
Currently, their heaviest sector is Health Care — making up 92.6% of
the total portfolio value.
The fund focuses on investments in the China as
33.3% of the portfolio companies
are based in the China.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
approximately 0.1% of the total holdings value.
On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $642 million.
These positions were updated on August 11th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Sinovac Biotech Ltd. |
No change
10,780,820
|
$405,359,000 | 92.64% |
| Huize Hldg Ltd |
26.46%
4,955,243
|
$29,533,000 | 6.75% |
| Qk Intl Group Ltd |
52.56%
1,897,700
|
$2,676,000 | 0.61% |
| No transactions found | |||
| Showing first 500 out of 3 holdings | |||